Integrity Research Clinical Associates

Integrity Research Clinical Associates is a clinical research organization based in Florida that actively participates in clinical trials for novel cancer therapies, including a Phase 1b study for the intratumoral siRNA immuno-oncology candidate PH-762, in partnership with Phio Pharmaceuticals[5]. The site is focused on investigator-initiated and industry-sponsored trials, particularly in oncology, and is currently enrolling patients for immuno-oncology studies[5]. There are no published clinical results at this time for programs with Integrity Research Clinical Associates as sponsor or lead site; available information pertains to its role as a clinical trial site for external sponsors.